|

Trifluridine-tipiracil plus Bevacizumab Alone Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Bevacizumab, Trifluridine-tipiracil

Pipeline

Phase 2: 1

Top Sponsors

  • Delcath Systems Inc.1

Indications

  • Liver Disease1
  • Refractory Metastatic Colorectal Cancer1
  • Liver Cancer1
  • Cancer1

Duarte, California1 trial

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

City of Hope

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.